Bitterroot Bio

Bitterroot Bio is a biotech company in Palo Alto, United States, founded in 2021. It has raised $145.0M across 1 round, most recently a $145.0M Series A in June 2023.

Pioneering cardio-immunology to transform cardiovascular medicine

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$145.0M
Last Round
$145.0M Series AJun 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Bitterroot Bio is pioneering cardio-immunology, which investigates the interplay between the immune system and cardiovascular health, to develop immunotherapies that treat cardiovascular disease rather than only its symptoms. The company builds on immunotherapy success in oncology by targeting immune cells and modulators that drive disease, including elevated CD47 in blood vessel walls that helps harmful cells evade macrophages and contribute to atherosclerotic plaque. Grounded in scientific research and collaboration with cardiologists, Bitterroot aims to slow or prevent plaque formation and transform how these diseases are treated.

Summary

It lists 11–50 employees. It has raised $145.0M in total across 1 round, most recently a $145.0M Series A round in Jun 2023. Investors include ARCH Venture Partners, Deerfield Management and GV.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJun 2023
$145.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bitterroot Bio on Indexed.vc
<a href="https://indexed.vc/companies/bitterroot-bio"><img src="https://indexed.vc/api/badge/company/bitterroot-bio" alt="Bitterroot Bio on Indexed.vc" width="260" height="76" /></a>